Show Notes
Host: Christopher L. Camp, M.D., Creator & Guide | Mayo Clinic Human Optimization Project
Guest: Saranya Wyles, M.D., Ph.D., Associate Professor of Dermatology and Regenerative MedicineDirector of Regenerative Dermatology and Skin Longevity LaboratoryMayo Clinic Department of Dermatology, Rochester, MN
Your skin is the largest organ in your body, and it does a lot more than just make you look good! It is our primary defense against the outside world and regulates many of our body’s internal functions. Given the major role it plays in our health and overall performance, it is important that we take care of our skin to keep it healthy for as long as possible.
Dr. Saryna Wyles is our expert guest here to answer these big questions for us: 1. What does our skin actually do for us and why is skin care so important? 2. How do we make sense of the most common skin care options out there and sort fact from fiction?What are the regular skin care3. practices we should be doing to help us have healthy, vibrant skin life long?
Learn more about the Human Optimization Project at: https://ce.mayo.edu/optimize
More from Tomorrow's Cure
How could Mayo Clinic’s Global AI Platform transform personalized care?
What if transplant patients could one day live free from lifelong anti-rejection drugs?
What happens when multiple sclerosis symptoms mask a different condition?
What if repairing damaged cartilage could be done in a single procedure? Using your own cells and the healing signals they need to recover?
What if the milk you are drinking could help fight cancer? In this episode of Tomorrow's Cure, we explore cholangiocarcinoma and a surprising new approach to targeting it using milk‑derived nanoparticles and precision aptamer‑based delivery. Host Lindsey Seavert is joined by surgical oncologist Dr. Rory Smoot and long‑term survivor and advocate Melinda Bachini to unpack why this cancer is so challenging, what symptoms and treatment paths patients typically face, and how emerging gene‑delivery platforms and AI‑driven discovery are opening new possibilities when standard therapies fall short. Through Melinda’s 16‑year survivorship story and Dr. Smoot’s lab work that literally starts with skim milk from the Mayo Clinic cafeteria, listeners hear how “chemical antibodies” called aptamers can act as molecular keys to deliver therapy directly to cholangiocarcinoma cells, and how computational tools are accelerating the search for new targets. Together, they discuss the emotional and practical realities of living at the edge of what medicine can do today, the expanding landscape of clinical trials, and why innovation in this rare cancer may ripple out to colon, lung and other hard‑to‑treat tumors.